Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice about its website transition and terminology appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study page itself continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:45:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:53:56.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an error screen. As a result, users cannot view the study overview, eligibility criteria, locations, or contacts.
    Difference
    18%
    Check dated 2026-09-23T01:11:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.6 to v3.7.0. This indicates a new build of the page system, typically reflecting maintenance or minor fixes rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-16T00:06:59.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6, signaling a minor update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-09-01T19:23:39.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision badge updated from v3.6.4 to v3.6.5, indicating a newer version of the study protocol/plan linked on the page. This reflects an update to the document version associated with the study record.
    Difference
    0.1%
    Check dated 2026-08-11T18:55:06.000Z thumbnail image

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.